Caffeine Occupancy of Human Cerebral A1Adenosine Receptors: In Vivo Quantification with18F-CPFPX and PET
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Caffeine is the neuroactive agent in coffee and tea and is a broadly consumed stimulant. It is a nonselective antagonist of the neuromodulator adenosine and, if applied in commonly consumed doses, evokes its stimulating effects through the blockade of adenosine receptors. (18)F-8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ((18)F-CPFPX) has been established as a highly selective and affine PET ligand for the A(1) adenosine receptor (A(1)AR). The objective of the present study was to visualize and quantify the in vivo occupancy of the human cerebral A(1)AR by caffeine using (18)F-CPFPX and PET. METHODS: Fifteen subjects (age range, 24-68 y) underwent a 140-min bolus-plus-constant-infusion PET experiment after at least 36 h of caffeine abstinence. Metabolite-corrected blood data were used to calculate steady-state distribution volumes (V(T)) during the baseline condition of the scan between 70 and 90 min. Subsequently, subjects received a 10-min infusion of varying concentrations (0.5-4.3 mg/kg of body weight) of caffeine at 90 min. Occupancy V(T) of the A(1)AR was thereafter estimated using data acquired between 120 and 140 min. Occupancy levels were calculated using the Lassen plot, from which the inhibitory concentrations of 50% were derived. Plasma levels of caffeine were determined at regular intervals. One subject received an intravenous vehicle as a placebo. RESULTS: Caffeine displaced 5%-44% of (18)F-CPFPX binding in a concentration-dependent manner. There was no change of radioligand binding after the administration of placebo. Half-maximal displacement was achieved at a plasma caffeine concentration of 67 μM, which corresponds to 450 mg in a 70-kg subject or approximately 4.5 cups of coffee. CONCLUSION: Given a biologic half-life of about 5 h, caffeine might therefore occupy up to 50% of the cerebral A(1)AR when caffeinated beverages are repeatedly consumed during a day. Furthermore, the present study provides evidence that (18)F-CPFPX PET is suitable for studying the cerebral actions of caffeine, the most popular neurostimulant worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“It is therefore likely that usually consumed amounts of coffee and caffeinated beverages (29) result in brain concentrations of caffeine that block substantial portions of cerebral A1ARs.”
BackgroundAdenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
Huang, Z.-L., Qu, W.-M., Eguchi, N., Chen, J.-F., Schwarzschild, M. A., Fredholm, B. B., Urade, Y., & Hayaishi, O. (2005) · Nature Neuroscience · doi:10.1038/nn1491 · Cited by 640
The absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378
Caffeine disposition after oral doses
Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.132 · Cited by 353 · cited 1×
“The consumption of approximately 3 cups of coffee corresponds to an oral uptake of 5–8 mg of caffeine per kilogram of bodyweight (7), leading to plasma peak levels of 8–10 mg/L (8,9).”
BackgroundArousal Effect of Caffeine Depends on Adenosine A2A Receptors in the Shell of the Nucleus Accumbens
Lazarus, M., Shen, H.-Y., Cherasse, Y., Qu, W.-M., Huang, Z.-L., Bass, C. E., Winsky-Sommerer, R., Semba, K., Fredholm, B. B., Boison, D., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6730-10.2011 · Cited by 327
Update on caffeine consumption, disposition and action
Mandel, H. G. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00093-5 · Cited by 240
Caffeine Reduces Low-Frequency Delta Activity in the Human Sleep EEG
Landolt, H. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00079-f · Cited by 198
Does caffeine modulate verbal working memory processes? An fMRI study
Koppelstaetter, F., Poeppel, T. D., Siedentopf, C. M., Ischebeck, A., Verius, M., Haala, I., Mottaghy, F. M., Rhomberg, P., Golaszewski, S., Gotwald, T., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.08.037 · Cited by 126 · cited 1×
“It is likely that the observed caffeine effects on the BOLD contrast are a combination of the increased neuronal activation (33) through a disinhibitory mechanism at the A1AR and a reduction of the cerebral blood flow (34) by inhibition of vascular A2A adenosine receptors.”
BackgroundCaffeine dose effect on activation-induced BOLD and CBF responses
Chen, Y., & Parrish, T. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.012 · Cited by 103
Chen, Y., & Parrish, T. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.09.057 · Cited by 100 · cited 1×
“It is likely that the observed caffeine effects on the BOLD contrast are a combination of the increased neuronal activation (33) through a disinhibitory mechanism at the A1AR and a reduction of the cerebral blood flow (34) by inhibition of vascular A2A adenosine receptors.”
Background
Cited by
Sleep and anxiety: From mechanisms to interventions
Chellappa, S. L., & Aeschbach, D. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101583 · Cited by 509
Time course of tolerance to the performance benefits of caffeine
Lara, B., Ruiz-Moreno, C., Salinero, J. J., & Del Coso, J. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210275 · Cited by 142
Beaumont, R., Cordery, P., Funnell, M., Mears, S., James, L., & Watson, P. (2017) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1241421 · Cited by 130
Bułdak, R. J., Hejmo, T., Osowski, M., Bułdak, Ł., Kukla, M., Polaniak, R., & Birkner, E. (2018) · Molecules · doi:10.3390/molecules23123309 · Cited by 89
“have shown that the consumption of 3 cups of coffee leads to caffeine levels in plasma equal to 8–10 mg/L [92].”
BackgroundRuiz-Moreno, C., Lara, B., Salinero, J. J., Brito de Souza, D., Ordovás, J. M., & Del Coso, J. (2020) · European Journal of Nutrition · doi:10.1007/s00394-019-02167-2 · Cited by 60
Metadata
- Authors
- Elmenhorst, D., Meyer, P. T., Matusch, A., Winz, O. H., & Bauer, A.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2012-09-10
- Volume
- 53
- Issue
- 11
- Pages
- 1723-1729
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2167785543
- Cited by
- 85
- References
- 10
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine Occupancy of Human Cerebral A1Adenosine Receptors: In Vivo Quantification with18F-CPFPX and PET. https://app.cochat.ai/papers/10.2967/jnumed.112.105114
- The paper
- Elmenhorst, D., Meyer, P. T., Matusch, A., Winz, O. H., & Bauer, A. (2012). Caffeine Occupancy of Human Cerebral A1Adenosine Receptors: In Vivo Quantification with18F-CPFPX and PET. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.112.105114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.